Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
BioNTech SE - American Depositary Shares
(NQ:
BNTX
)
92.50
+1.04 (+1.14%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioNTech SE - American Depositary Shares
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
71
72
Next >
Why Is Novavax (NVAX) Stock Falling Today?
↗
September 22, 2022
Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.
Via
InvestorPlace
Nikola, Super Micro Computer And Other Big Losers From Monday
↗
September 20, 2022
U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Check Out What Whales Are Doing With BNTX
↗
September 19, 2022
Someone with a lot of money to spend has taken a bullish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
↗
September 19, 2022
Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now?
Via
InvestorPlace
Why BioNTech, Moderna And Novavax Shares Are Diving
↗
September 19, 2022
BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo
Via
Benzinga
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
↗
September 14, 2022
Via
Benzinga
The Silver Lining For Pfizer, Moderna In This Month's IBD/TIPP Poll
↗
September 15, 2022
The companies recently launched their updated Covid booster shots.
Via
Investor's Business Daily
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
↗
September 12, 2022
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 12, 2022
From
Pfizer Inc.
Via
Business Wire
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
↗
September 09, 2022
Via
Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
↗
September 06, 2022
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
↗
September 02, 2022
Via
Benzinga
Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters
↗
September 02, 2022
These new shots target the BA.4 and BA.5 subvariants of omicron.
Via
Investor's Business Daily
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
↗
September 01, 2022
Via
Benzinga
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
↗
September 01, 2022
Health Canada has approved Moderna Inc's (NASDAQ:
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 01, 2022
From
Pfizer Inc.
Via
Business Wire
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
↗
September 01, 2022
Wall Street Journal
Via
Benzinga
Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News
↗
August 31, 2022
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use...
Via
Benzinga
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
August 31, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer, Moderna Nab FDA Authorization For Updated Covid Boosters
↗
August 31, 2022
Boosters are recommended two months out from the last shot.
Via
Investor's Business Daily
Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30
↗
August 30, 2022
Reuters Taiwan’s China Airlines Orders 16 Boeing 787s
Via
Benzinga
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers
↗
August 30, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the...
Via
Benzinga
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
↗
August 30, 2022
Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
↗
August 26, 2022
Via
Benzinga
Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine
↗
August 26, 2022
Via
Benzinga
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
August 26, 2022
From
Pfizer Inc.
Via
Business Wire
Moderna Claims Pfizer, BioNTech Stole Its Patented Tech In Covid Shot
↗
August 26, 2022
The lawsuit alleges Comirnaty violates Moderna's patents from 2010-16.
Via
Investor's Business Daily
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
↗
August 26, 2022
Moderna Inc (NASDAQ: MRNA) has
Via
Benzinga
Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late?
↗
August 26, 2022
The companies hope to launch updated boosters this fall. This is what experts think of their prospects.
Via
Investor's Business Daily
AstraZeneca's CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions
↗
August 24, 2022
In a Reuters report, AstraZeneca Plc's (NASDAQ:
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
71
72
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.